About Eolo Pharma
Eolo Pharma is a company based in Sunchales (Argentina) founded in 2017 by Virginia Lopez and Pia Garat.. Eolo Pharma has raised $4.5 million across 2 funding rounds from investors including CITES and Paul Elberse. Eolo Pharma offers products and services including MVD1 and NCE Library. Eolo Pharma operates in a competitive market with competitors including Aclaris Therapeutics, Escient Pharmaceuticals, Nimbus Therapeutics, Alpine Immune Sciences and Septerna, among others.
- Headquarter Sunchales, Argentina
- Founders Virginia Lopez, Pia Garat
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$4.5 M (USD)
in 2 rounds
-
Latest Funding Round
$1.8 M (USD), Series A
Feb 08, 2023
-
Investors
CITES
& 1 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Eolo Pharma
Eolo Pharma offers a comprehensive portfolio of products and services, including MVD1 and NCE Library. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Lead compound targeting obesity and related conditions
Collection of novel molecules for various health indications
Unlock access to complete
Unlock access to complete
Funding Insights of Eolo Pharma
Eolo Pharma has successfully raised a total of $4.5M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $1.8 million completed in February 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series A — $1.8M
-
First Round
First Round
(31 Dec 2019)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb, 2023 | Amount | Series A - Eolo Pharma | Valuation |
investors |
|
| Dec, 2019 | Amount | Series A - Eolo Pharma | Valuation | Paul Elberse |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Eolo Pharma
Eolo Pharma has secured backing from 2 investors, including institutional and angel investors. Prominent investors backing the company include CITES and Paul Elberse. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
PE
Paul Elberse |
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Eolo Pharma
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Eolo Pharma
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Eolo Pharma Comparisons
Competitors of Eolo Pharma
Eolo Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Aclaris Therapeutics, Escient Pharmaceuticals, Nimbus Therapeutics, Alpine Immune Sciences and Septerna, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Novel dermatologic therapies are developed for skin conditions.
|
|
| domain | founded_year | HQ Location |
Small molecule therapeutics for inflammatory diseases are developed.
|
|
| domain | founded_year | HQ Location |
Targeted therapeutics for cancer, metabolic, and inflammatory diseases are developed.
|
|
| domain | founded_year | HQ Location |
Developer of immunotherapies to treat cancer and autoimmune disorders
|
|
| domain | founded_year | HQ Location |
GPCR drug discovery platform is developed for multiple diseases.
|
|
| domain | founded_year | HQ Location |
Therapeutics for allergic and inflammatory diseases are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Eolo Pharma
When was Eolo Pharma founded?
Eolo Pharma was founded in 2017 and raised its 1st funding round 2 years after it was founded.
Where is Eolo Pharma located?
Eolo Pharma is headquartered in Sunchales, Argentina. It is registered at Sunchales, Santa Fe, Argentina.
Who is the current CEO of Eolo Pharma?
Pia Garat is the current CEO of Eolo Pharma. They have also founded this company.
Is Eolo Pharma a funded company?
Eolo Pharma is a funded company, having raised a total of $4.5M across 2 funding rounds to date. The company's 1st funding round was a Series A of $2.7M, raised on Dec 31, 2019.
What does Eolo Pharma do?
Eolo Pharma is developing therapies for treating inflammation-related diseases (autoinflammatory and autoimmune diseases). Their lead candidate, EOLO3, which is used to treat metabolic syndrome. The candidate is in phase I clinical trial. The other candidates are in the preclinical stage.
Who are the top competitors of Eolo Pharma?
Eolo Pharma's top competitors include Escient Pharmaceuticals, Nimbus Therapeutics and Alpine Immune Sciences.
What products or services does Eolo Pharma offer?
Eolo Pharma offers MVD1 and NCE Library.
Who are Eolo Pharma's investors?
Eolo Pharma has 2 investors. Key investors include CITES, and Paul Elberse.